Date: 5 July 2018 - 6 July 2018
Location: The Royal College of Physicians, London
Duration: Two days
CPD: 12 hours
A holistic approach to menopause care: HRT and beyond
‘Largest annual conference in Europe on menopause and post-reproductive health’
This year’s conference programme has been designed to provide a comprehensive range of lectures and workshops to refresh and broaden your knowledge of post-reproductive health and to give you the confidence to manage the menopause in the way you feel is best.
Presented by leading experts, both national and international. There will be a medical exhibition running alongside the Conference.
|Who should attend:||The conference is open to all health professionals – GPs, clinic doctors, gynaecologists, specialist and practice nurses, academics, O&G and GP trainees. We also welcome anyone allied to the health profession with an interest in women’s health.|
|Booking:||Our conference is now FULLY BOOKED but you may like to add your name to the waiting list:|
|Speakers and their biographies:||Full details of programme and speakers (including biographies):
BMS 28th Annual Conference programme – Day 1
BMS 28th Annual Conference programme – Day 2
|Call for abstracts:||THE ABSTRACT SUBMISSION DEADLINE HAS NOW PASSED|
|Enquiries:||Kate Ellis 01628 890199 firstname.lastname@example.org|
Programme Planning Group
The Programme Planning Group, jointly chaired by Mike Savvas and Haitham Hamoda, has produced an excellent line up including the International Menopause Society invited session chaired by Professor Mary Ann Lumsden; the debate, which this year is This house believes that menopausal women receiving HRT should be advised to undergo hysterectomy to benefit from oestrogen only HRT instead of combined HRT and the ever popular Menopause Café.
The group consists of the following members (click on names for more details):
This Conference is financially supported in part by the pharmaceutical industry through sponsorship but it has no influence over the Conference agenda.
All lecturers are required to make a formal declaration of interests at the beginning of their presentation.
From our beginnings nearly 140 years ago in Osaka, Japan, Shionogi & Co. Ltd. has built a strong heritage in research-based medicine, matched by world-class market access and patient insight capabilities. More
Bayer is committed to developing innovative treatments and, with a long heritage in Women’s Healthcare, has an ongoing commitment to offer a wide range of effective short- and long-acting contraception methods. More